1
2
#OpenInnovation
3
4
News & Events
InterVenn Biosciences to make Malaysia its regional hub
August 3, 2022
Malaysia as regional hub for delivery of InterVenn's services and products in ASEAN & APAC. Read more
InterVenn Biosciences Announces Start of Enrollment in Colonoscopy Study
August 2, 2022
NICE Study is intended to validate InterVenn's platform to detect early colorectal cancers. Read more
Congenica appoints Robert Denison as CEO
June 22, 2022
Rob will also join the Board of the company. Read more
5
#knowledgebase
6
7
News & Events
InterVenn Biosciences to make Malaysia its regional hub
August 3, 2022
Malaysia as regional hub for delivery of InterVenn's services and products in ASEAN & APAC. Read more
InterVenn Biosciences Announces Start of Enrollment in Colonoscopy Study
August 2, 2022
NICE Study is intended to validate InterVenn's platform to detect early colorectal cancers. Read more
Congenica appoints Robert Denison as CEO
June 22, 2022
Rob will also join the Board of the company. Read more
8
Portfolio Highlights
#PharmaBiotech
11
Our View
10
Our Focus
12
#PRI
22
Medical Technologies
#Portfolio
14
Championing
collaborations
that improve health
and the quality of life
for everyone.
#JoinForces
#LifeSciencesInTheFuture
16
Words from
the CEO
17
Portfolio Highlights
#PharmaBiotech
28
Pharmaceutical Biotech
#Portfolio
15
About Us
34
Biorenewables & Others
#Portfolio
19
WHAT'S TRENDING @ XERAYA
InterVenn establishes Malaysia as regional hub
20
Our Team
21
23
Portfolio Highlights
#Biorenewables
30
Portfolio Highlights
#MedTech
25
26
ARE YOU
The Next
Big Thing?
Submit
A
Proposal
29
36
Career
#Xeraya
35
37
News & Events
InterVenn Biosciences to make Malaysia its regional hub
August 3, 2022
Malaysia as regional hub for delivery of InterVenn's services and products in ASEAN & APAC. Read more
InterVenn Biosciences Announces Start of Enrollment in Colonoscopy Study
August 2, 2022
NICE Study is intended to validate InterVenn's platform to detect early colorectal cancers. Read more
Congenica appoints Robert Denison as CEO
June 22, 2022
Rob will also join the Board of the company. Read more
32
#agro
33
Portfolio Highlights
#Biorenewables
38
Portfolio Highlights
#MedTech
39
40
Contact Us
41
